We are live on ! Find out more
FC

Finepoint Capital Portfolio holdings

AUM $1.95B
1-Year Est. Return 45.61%
This Fund
S&P 500
This Quarter Est. Return
+0.09%
1 Year Est. Return
+45.61%
3 Year Est. Return
+24.83%
5 Year Est. Return
+26.66%
10 Year Est. Return
AUM
$390M
AUM Growth
-$196M
Cap. Flow
-$195M
Cap. Flow %
-50.11%
Top 10 Hldgs %
46.7%
Holding
87
New
13
Increased
Reduced
6
Closed
16
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KAHC
1
DELISTED
KKR Acquisition Holdings I Corp.
KAHC
$22.9M 5.88%
2,354,195
GTPB
2
DELISTED
Gores Technology Partners II, Inc. Class A Common
GTPB
$22.3M 5.72%
2,253,459
REVH
3
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock
REVH
$21M 5.38%
2,163,205
APGB
4
DELISTED
Apollo Strategic Growth Capital II
APGB
$18.4M 4.72%
1,881,344
HAAC
5
DELISTED
Health Assurance Acquisition Corp. Class A Common Stock
HAAC
$18M 4.6%
1,838,417
CCV
6
DELISTED
Churchill Capital Corp V
CCV
$17.8M 4.56%
1,806,000
CCVI
7
DELISTED
Churchill Capital Corp VI
CCVI
$16.7M 4.28%
1,706,000
CPAR
8
DELISTED
Catalyst Partners Acquisition Corp. Class A Ordinary Share
CPAR
$16.4M 4.2%
1,683,334
IPOF
9
DELISTED
Social Capital Hedosophia Holdings Corp. VI
IPOF
$15.8M 4.05%
1,549,000
BTWN
10
DELISTED
Bridgetown Holdings Limited Class A Ordinary Shares
BTWN
$12.9M 3.32%
1,317,200
CNDA
11
DELISTED
Concord Acquisition Corp II
CNDA
$11.9M 3.06%
+1,225,000
New +$12M
KVSC
12
DELISTED
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
$11.8M 3.04%
1,214,000
AFTR
13
DELISTED
AfterNext HealthTech Acquisition Corp
AFTR
$10.7M 2.75%
+1,100,000
New +$10.7M
SKYA
14
DELISTED
Skydeck Acquisition Corp. Class A Ordinary Shares
SKYA
$10.6M 2.73%
1,085,270
CORS
15
DELISTED
Corsair Partnering Corporation
CORS
$9.8M 2.51%
1,004,000
IVCPU
16
DELISTED
Swiftmerge Acquisition Corp. Unit
IVCPU
$9.79M 2.51%
+980,000
New +$9.72M
AKLI
17
DELISTED
Akili Inc
AKLI
$9.73M 2.49%
980,000
PROK icon
18
ProKidney
PROK
$332M
$9.7M 2.49%
980,000
DNAB
19
DELISTED
Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares
DNAB
$9.69M 2.48%
980,000
SNRH
20
DELISTED
Senior Connect Acquisition Corp. I Class A Common Stock
SNRH
$9.67M 2.48%
992,937
-899,938
-48% -$8.8M
FCAX
21
DELISTED
Fortress Capital Acquisition Corp.
FCAX
$9.66M 2.48%
989,818
-897,274
-48% -$8.78M
DNAD
22
DELISTED
Social Capital Suvretta Holdings Corp. IV Class A Ordinary Shares
DNAD
$9.62M 2.47%
980,000
SMIH
23
DELISTED
Summit Healthcare Acquisition Corp. Class A Ordinary Share
SMIH
$9.53M 2.44%
980,000
DGNU
24
DELISTED
Dragoneer Growth Opportunities Corp. III Class A Ordinary Shares
DGNU
$9.48M 2.43%
969,959
-879,466
-48% -$8.71M
CVII
25
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
$8.81M 2.26%
896,750
-1,000,000
-53% -$9.8M

Similar funds

Finepoint Capital's Q4 2021 Portfolio in Review

As of Q4 2021, Finepoint Capital held 87 positions worth $390M, down 33% from $586M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Finepoint Capital withdrew a net $195M in Q4 2021, closing 16 positions and reducing 6 holdings. Its most notable exit was Spartan Acquisition Corp. III, an estimated $18.6M position sold in full.

By sector, the portfolio is most concentrated in Financials at 88% of assets, up from 71% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Finepoint Capital opened a new position in Concord Acquisition Corp II worth $11.9M.

  • Finepoint Capital's largest Q4 2021 buy was Concord Acquisition Corp II: 1,225,000 shares worth $11.9M.
  • Finepoint Capital's biggest Q4 2021 reduction was Churchill Capital Corp VII Class A Common Stock, cutting an estimated $9.8M.
  • Finepoint Capital fully exited Spartan Acquisition Corp. III in Q4 2021, selling an estimated $18.6M.
  • Finepoint Capital's ten largest holdings make up 47% of its $390M portfolio in Q4 2021.
  • Finepoint Capital opened 13 new positions and closed 16 in Q4 2021.
  • Finepoint Capital's portfolio value fell 33% quarter-over-quarter to $390M.

Based on Finepoint Capital's 13F filing for Q4 2021, filed 11 Feb 2022.